Neferine alleviates ovalbumin-induced asthma via MAPK signaling pathways in mice

Main Article Content

Tonggang Zhu
Xue Xiao
Yufu Dong
Chengbo Yuan

Keywords

airway resistance, asthma, lung injury, MAPK pathways, neferine

Abstract

Purpose: To investigate the role of neferine in ovalbumin (OVA)-induced asthma, and to reveal the possible mechanism.


Methods: In OVA-induced asthmatic mice, enzyme-linked-immunosorbent serologic assay was performed to evaluate the level of interleukin (IL)-4, IL-5, IL-13, immunoglobulin E (IgE) in serum and tumor necrosis factor-α (TNF-α), IL-6, IL-1β, and monocyte chemoattractant protein-1 (MCP-1) in bronchoalveolar lavage fluid (BALF). Eosinophil, neutrophil, and lymphocyte counts in BALF were calculated to assess inflammation. The pulmonary function was measured by airway resistance, peak expiratory flow (PEF) and forced expiratory volume/forced vital capacity (FEV0.4/FVC) ratio, and respiratory rate. Hematoxylin and eosin staining and Masson staining were used to evaluate lung injury. Further, Western blot analysis was conducted to detect phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 of mitogen-activated protein kinase (MAPK) signaling pathways.


Results: Neferine, 20 mg/kg or 40 mg/kg, could significantly decrease the levels of IL-4, IL-5, IL-13, and IgE in OVA-induced serum, and that of TNF-α, IL-6, IL-1β, and MCP-1 in OVA-induced BALF. Moreover, neferine could significantly decline eosinophil, neutrophil, and lymphocyte counts in BALF. Neferine contributed to improve OVA-induced airway resistance, promoted the value of PEF and FEV0.4/FVC ratio, and recovered the respiratory rate. It also reduced mucus secretion, distribution of inflammatory and goblet cells around bronchi, and attenuated collagen deposition in lung tissues. Furthermore, neferine reduced the phosphorylation of p38, JNK, and ERK to inhibit MAPK signaling pathways.


Conclusion: Neferine relieves asthma-induced inflammatory reaction, airway resistance, and lung injury by inhibiting MAPK signaling pathways. This could serve neferine as a novel therapeutic candidate for treating asthma.

Abstract 485 | PDF Downloads 685 HTML Downloads 53 XML Downloads 4

References

1. Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. New Engl J Med. 2022,386(2):157–171. 10.1056/NEJMra2032506

2. Jin X, Jin W, Li G, Zheng J. Zeaxanthin attenuates OVA-induced allergic asthma in mice by regulating the p38 MAPK/β-catenin signaling pathway. Allergologia et Immunopathologia. 2022;50(5):75–83. 10.15586/aei.v50i5.664

3. Zhou R, Chen X. Dexmedetomidine represses TGF-β1-induced extracellular matrix production and proliferation of airway smooth muscle cells by inhibiting MAPK signaling pathway. Allergologia et Immunopathologia. 2022;50(2):16–22. 10.15586/aei.v50i2.505

4. Santana FP, da Silva RC, Ponci V, Pinheiro AJ, Olivo CR, Caperuto LC, et al. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. Biochem Pharmacol. 2020;180:114175. 10.1016/j.bcp.2020.114175

5. Qi Z, Wang R, Liao R, Xue S, Wang Y. Neferine ameliorates sepsis-induced myocardial dysfunction through anti-apoptotic and antioxidative effects by regulating the PI3K/AKT/mTOR signaling pathway. Front Pharmacol. 2021;12:706251. 10.3389/fphar.2021.706251

6. Wang Y, Wang S, Wang R, Li S, Yuan Y. Neferine exerts antioxidant and anti-inflammatory effects on carbon tetrachloride-induced liver fibrosis by inhibiting the MAPK and NF-κB/IκBα pathways. Evid Based Complement Alternat Med. 2021;2021:4136019. 10.1155/2021/4136019

7. Chiu K-M, Hung Y-L, Wang S-J, Tsai Y-J, Wu N-L, Liang C-W, et al. Anti-allergic and anti-inflammatory effects of neferine on RBL-2H3 cells. Int J Mol Sci. 2021;22(20):10994. 10.3390/ijms222010994

8. Jia S, Guo P, Lu J, Huang X, Deng L, Jin Y, et al. Curcumol ameliorates lung inflammation and airway remodeling via inhibiting the abnormal activation of the Wnt/β-catenin pathway in chronic asthmatic mice. Drug Design Develop Ther. 2021;15:2641. 10.2147/DDDT.S292642

9. Bai D, Sun T, Lu F, Shen Y, Zhang Y, Zhang B, et al. Eupatilin suppresses OVA-induced asthma by inhibiting NF-κB and MAPK and activating Nrf2 signaling pathways in mice. Int J Mol Sci. 2022;23(3):1582. 10.3390/ijms23031582

10. Zeng Z, Lin X, Zheng R, Zhang H, Zhang W. Celastrol alleviates airway hyperresponsiveness and inhibits Th17 responses in obese asthmatic mice. Front Pharmacol. 2018;9:49. 10.3389/fphar.2018.00049

11. Dogan MF, Parlar A, Cam SA, Tosun EM, Uysal F, Arslan SO. Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma. Pulmonary Pharmacol Ther. 2020:63:101936. 10.1016/j.pupt.2020.101936

12. Li JT, O’Connell EJ. Clinical evaluation of asthma. Ann Allergy Asthma Immunol. 1996;76(1):1–15. 10.1016/S1081-1206(10)63400-X

13. Li C, Deng C, Zhou T, Hu J, Dai B, Yi F, et al. MicroRNA-370 carried by M2 macrophage-derived exosomes alleviates asthma progression through inhibiting the FGF1/MAPK/STAT1 axis. Int J Biol Sci. 2021;17(7):1795. 10.7150/ijbs.59715

14. Sun X, Hou T, Cheung E, Iu TN-T, Tam VW-H, Chu IM-T, et al. Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma. Cell Mol Immunol. 2020;17(6):631–646. 10.1038/s41423-019-0300-7

15. Klotz LO, Pellieux C, Briviba K, Pierlot C, Aubry JM, Sies H. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur J Biochem. 1999;260(3):917–922. 10.1046/j.1432-1327.1999.00255.x

16. Xie L, Dong J, Wu J, Wei C, Xu K, Lai P, et al. Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy. Tropical J Pharma Res. 2022;21(5):939–942. 10.4314/tjpr.v21i5.5